Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro does not typically cause easy bruising as a pharmacological effect — bruising at the injection site is common and usually minor, but it is a local skin response rather than a sign the medicine is affecting your blood or clotting. Most people notice a small, tender bruise where the pen was used, and it resolves within a few days. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist prescribed for weight management in adults who meet clinical criteria; like all prescription-only medicines, it is assessed by a prescriber before use, because individual health factors (including any medications that affect bleeding) matter when deciding whether it is suitable for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most straightforward reason people bruise after a Mounjaro injection is mechanical. The pre-filled KwikPen inserts a fine needle into the fatty layer just beneath the skin. If it passes through or near a small superficial blood vessel, blood leaks into the surrounding tissue and produces the characteristic purple-blue mark. This is the same thing that happens with any subcutaneous injection, from insulin to vaccines. It is not specific to tirzepatide.
The NHS medicines page for tirzepatide lists injection-site reactions, including bruising, redness and soreness, as common side effects. Common in this context means they affect between one in ten and one in one hundred people, so if you have had a bruise after your pen, you are far from alone. In clinical practice, many people find the bruise is more noticeable at lower doses when they are still getting used to the technique, and less so over time as their confidence and injection rotation improve.
One practical tip: keep your pen at room temperature for a few minutes before injecting rather than using it straight from the fridge. Cold liquid travelling into tissue can cause a sharper local reaction. Most people keep their pen in the fridge door alongside everyday items and take it out ten minutes before the scheduled injection, a small habit that can make a genuine difference to comfort.
A reasonable concern behind this question is whether tirzepatide somehow alters how your blood clots, making you bruise more easily across your whole body. The short answer is no. Tirzepatide is a receptor agonist that acts on GIP and GLP-1 receptors; it does not affect platelet function, clotting factors or vascular integrity. There is no known pharmacological mechanism by which it would cause systemic easy bruising.
If you have started Mounjaro and noticed bruising in places unrelated to injections, the most likely explanations have nothing to do with the medicine itself. Common culprits include other medications you may already be taking, particularly anticoagulants, NSAIDs or corticosteroids; nutritional deficiencies, including low vitamin C, vitamin K or iron; or an underlying health condition that pre-dates treatment. For more detail on bruising patterns reported by people on Mounjaro, our dedicated page walks through the most common scenarios.
The key distinction to hold in mind is localised versus widespread. A bruise at the site where you injected three days ago is expected and harmless. Bruises appearing spontaneously across your arms, legs or torso, or bruises that take unusually long to fade, deserve clinical attention regardless of what medicine you are taking.
Technique matters far more than most people realise when it comes to bruising after a Mounjaro injection. A few adjustments can significantly reduce frequency and size. Rotate sites consistently: the abdomen, outer thigh and upper arm are all suitable, and moving to a fresh area each week means any one spot gets time to recover. Within each area, shift the exact point by at least two centimetres from the previous injection.
Pinching the skin gently before inserting the needle, then releasing the pinch before withdrawing, can reduce the chance of catching a vessel. After the injection, apply gentle pressure with a clean fingertip for ten seconds rather than rubbing the area, which can spread any leaked blood further into the tissue. If you want to understand why a bruise from Mounjaro forms and how long it typically lasts, our dedicated page covers what to expect and when to seek advice. Avoid injecting directly into an area that already shows a bruise or is still tender from a previous dose.
If bruising remains a consistent problem despite good technique, it is worth mentioning at your next clinical review. A prescriber can look at whether any concurrent medication may be contributing and offer personalised advice. You can reach our aftercare team seven days a week if a question cannot wait for your next scheduled review.
Most injection-site bruises are genuinely harmless, tender for a day or two, visible for up to a week, then gone. There are situations, though, where it is right to contact a healthcare professional without waiting. Seek prompt advice if a bruise at the injection site becomes hot, swollen, increasingly painful or begins to look infected (spreading redness, pus, warmth extending beyond the bruise). These signs suggest a skin infection rather than straightforward bruising.
Seek urgent medical help if you develop signs of a serious allergic reaction, including swelling of the face, lips or throat, difficulty breathing, or a spreading rash. These are listed in the MHRA's Yellow Card reporting guidance as events to report and to act on immediately, not to monitor at home. For a broader look at what Mounjaro is, how it works and what it is licensed for in the UK, our main Mounjaro page covers the full picture.
If you are considering starting treatment and want to understand how a prescriber would assess your suitability, including any medications you take that might affect how you respond, our cost and treatment overview explains what a private consultation with nume includes. The right starting point is always a clinical conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.